Bank Of Montreal Harmony Biosciences Holdings, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$30.5 - $37.4 $2.43 Million - $2.98 Million	79,754 New	79,754 $2.81 Million
Q2 2022 Aug 11, 2022	SELL	$33.54 - $52.15 $204,090 - $317,332	-6,085 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$33.14 - $51.13 $5,468 - $8,436	165 Added 2.79%	6,085 $307,000
Q4 2021 Feb 11, 2022	BUY	$34.09 - $43.91 $201,812 - $259,947	5,920 New	5,920 $263,000

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.